CN101636146A - 眼科药物组合物及其用途 - Google Patents

眼科药物组合物及其用途 Download PDF

Info

Publication number
CN101636146A
CN101636146A CN200780031963A CN200780031963A CN101636146A CN 101636146 A CN101636146 A CN 101636146A CN 200780031963 A CN200780031963 A CN 200780031963A CN 200780031963 A CN200780031963 A CN 200780031963A CN 101636146 A CN101636146 A CN 101636146A
Authority
CN
China
Prior art keywords
compositions
eyes
chemical compound
viscosity adjustment
environment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200780031963A
Other languages
English (en)
Chinese (zh)
Inventor
夏尔宁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bausch and Lomb Inc
Original Assignee
Bausch and Lomb Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch and Lomb Inc filed Critical Bausch and Lomb Inc
Publication of CN101636146A publication Critical patent/CN101636146A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN200780031963A 2006-08-30 2007-08-24 眼科药物组合物及其用途 Pending CN101636146A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84103606P 2006-08-30 2006-08-30
US60/841,036 2006-08-30

Publications (1)

Publication Number Publication Date
CN101636146A true CN101636146A (zh) 2010-01-27

Family

ID=38969502

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200780031963A Pending CN101636146A (zh) 2006-08-30 2007-08-24 眼科药物组合物及其用途

Country Status (5)

Country Link
US (1) US20080057022A1 (enExample)
EP (1) EP2068821A2 (enExample)
JP (1) JP2010502634A (enExample)
CN (1) CN101636146A (enExample)
WO (1) WO2008027793A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105251027A (zh) * 2014-06-26 2016-01-20 通用电气医疗集团股份有限公司 脂质灭菌方法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100087550A1 (en) 2008-10-06 2010-04-08 Zora Marlowe Formulations with a Tertiary Amine Oxide
US9125405B2 (en) * 2008-10-28 2015-09-08 Bausch & Lomb Incorporated Contact lens solution with a tertiary amine oxide
US20110029950A1 (en) * 2009-07-30 2011-02-03 Iftach Ragoler Computer-readable media, methods and computer systems for designing a software application graphically
GB2484843A (en) * 2009-10-15 2012-04-25 Johnson Matthey Plc Polymorphs of Bromfenac sodium
US20220160668A1 (en) 2020-11-23 2022-05-26 Sight Sciences, Inc. Formulations and methods for treating conditions of the eye

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798053A (en) * 1952-09-03 1957-07-02 Goodrich Co B F Carboxylic polymers
US4192827A (en) * 1974-06-27 1980-03-11 Ciba-Geigy Corporation Water-insoluble hydrophilic copolymers
US4136250A (en) * 1977-07-20 1979-01-23 Ciba-Geigy Corporation Polysiloxane hydrogels
US4883658A (en) * 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
US4804539A (en) * 1986-07-28 1989-02-14 Liposome Technology, Inc. Ophthalmic liposomes
US4914088A (en) * 1987-04-02 1990-04-03 Thomas Glonek Dry eye treatment solution and method
US5278151A (en) * 1987-04-02 1994-01-11 Ocular Research Of Boston, Inc. Dry eye treatment solution
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5075104A (en) * 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
ZA912797B (en) * 1990-05-29 1992-12-30 Boston Ocular Res Dry eye treatment process and solution
ATE132366T1 (de) * 1990-05-29 1996-01-15 Boston Ocular Res Zusammensetzung zur behandlung von dry eye erkrankungen
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
TW274516B (enExample) * 1993-11-12 1996-04-21 Ciba Geigy Ag
SE9401109D0 (sv) * 1994-03-31 1994-03-31 Leiras Oy Opthalmic composition II
US7056893B2 (en) * 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US7001615B1 (en) * 2001-12-07 2006-02-21 Alcon, Inc. Sustained release ophthalmic, otic and nasal suspension
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
KR101147046B1 (ko) * 2003-06-13 2012-05-22 알콘, 인코퍼레이티드 시너지성의 2개의 폴리머 배합물을 포함하는 안과용 조성물
US8569367B2 (en) * 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
TWI358290B (en) * 2004-12-02 2012-02-21 Alcon Inc Topical nepafenac formulations
WO2007005421A2 (en) * 2005-07-01 2007-01-11 Bausch & Lomb Incorporated Long lasting alginate dry eye, related methods of manufacture and methods of use
WO2007058935A2 (en) * 2005-11-14 2007-05-24 Bausch & Lomb Incorporated Ophthalmic composition for dry eye therapy
US20070287752A1 (en) * 2006-06-08 2007-12-13 Burke Susan E Ophthalmic Compositions Comprising A Branched, Glycerol Compound

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105251027A (zh) * 2014-06-26 2016-01-20 通用电气医疗集团股份有限公司 脂质灭菌方法
US10888631B2 (en) 2014-06-26 2021-01-12 Ge Healthcare As Lipid sterilization method

Also Published As

Publication number Publication date
WO2008027793A2 (en) 2008-03-06
WO2008027793A3 (en) 2008-04-17
EP2068821A2 (en) 2009-06-17
US20080057022A1 (en) 2008-03-06
JP2010502634A (ja) 2010-01-28

Similar Documents

Publication Publication Date Title
US12059449B2 (en) Ophthalmic composition for treatment of dry eye disease
TWI361701B (en) Ophthalmic formulation for the prevention and treatment of adverse ocular conditions, particularly those associated with the aging eye
CA2987787C (en) Compositions for the improvement of distance vision and the treatment of refractive errors of the eye
US20110294897A1 (en) Treating Xerophthalmia With Compounds Increasing Meibomian Gland Secretion
JP2021138760A (ja) セチリジンの眼科用製剤および使用方法
US9314427B2 (en) Compositions and methods for the improvement of distance vision and the treatment of refractive errors of the eye
JP2024037806A (ja) ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの製剤
CN101977595A (zh) 用于治疗以及预防眼睑肿胀的组合物
CN101636146A (zh) 眼科药物组合物及其用途
CA3072494A1 (en) Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye
KR20140069210A (ko) 안과적 겔 조성물
RU2828769C2 (ru) Офтальмологические композиции для лечения синдрома сухого глаза
TWI805705B (zh) 選擇性syk抑制劑之使用方法及醫藥組合物
JP2024178335A (ja) ゲランガムおよびフェニレフリンに基づく組成物、製造方法、ならびに眼科用生成物としての使用
CN110179748A (zh) 一种缓解眼部炎症及过敏症状滴眼液及其制备方法
WO2025236782A1 (zh) 一种用于治疗眼部病症的组合物
WO2024194763A1 (en) Pharmaceutical compositions comprising apraclonidine for ocular redness relief
HK40114301A (en) Ophthalmic composition for treatment of dry eye disease
CN116270442A (zh) 一种用于矫正近距离视力的眼用制剂
CN115702879A (zh) 一种硫酸阿托品的滴眼液
HK40058504B (en) Ophthalmic composition for treatment of dry eye disease
HK40058504A (en) Ophthalmic composition for treatment of dry eye disease

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20100127